The most cutting-edge form of neurofeedback has the most promise and was recently given a boost by the FDA. This is the only time the FDA has addressed any particular form of neurofeedback.

A study using low-level laser photobiomodulation (PBM) shows promise for reduced irritability and other symptoms in 5-17 year olds on the autism spectrum. These improvements were maintained over time.

Photobiomodulation (PBM) is a form of light therapy that's showing promise in the field of neuropsychiatry. This innovative approach uses specific wavelengths of light to stimulate the brain, aiming to improve symptoms of various conditions. I’m on the scientific advisory council for Neuronic, a company that makes PBM devices.

Explore new research that sheds light on a potential mechanism contributing to the neurological and cognitive symptoms seen in Long COVID – a reduction in serotonin levels. And we’ll cover the possibility of using photobiomodulation (PBM) to address long-COVID symptoms. Photobiomodulation is a treatment that uses special light to help cells work better and promote healing.

This is a lovely study in a major journal that adds to the evidence for psychedelic-assisted psychotherapy. It is sham-controlled, and shows sustained relief from depressive symptoms after a single session of psilocybin assisted psychotherapy for those with major depression compared to the sham.

A new study came out this month about the memory benefits of noninvasive stimulation. As someone who uses this technique every day in my office, I’m thrilled to see more coverage of the latest science.